Yayın: Activity and safety of a combination of Epirubicin, Docetaxel and Cisplatin as neoadjuvant treatment for locally advanced breast cancer (LABC): A preliminary report
| dc.contributor.buuauthor | Avcı, Nilüfer | |
| dc.contributor.buuauthor | Kanat, Özkan | |
| dc.contributor.buuauthor | Gökgöz, Şehsuvar | |
| dc.contributor.buuauthor | Tolunay, Şahsine | |
| dc.contributor.buuauthor | Topal, Uğur | |
| dc.contributor.buuauthor | Çubukçu, Erdem | |
| dc.contributor.buuauthor | Ölmez, Fatih | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.researcherid | AAI-1612-2021 | |
| dc.date.accessioned | 2022-02-16T07:05:18Z | |
| dc.date.available | 2022-02-16T07:05:18Z | |
| dc.date.issued | 2012-09 | |
| dc.description | Bu çalışma, 28 Eylül-02 Ekim 2012 tarihleri arasında Vienna[Austria]’da düzenlenen 37. Congress of the European-Society-for-Medical-Oncology (ESMO)’da bildiri olarak sunulmuştur. | |
| dc.description.sponsorship | European Soc Med Oncol (ESMO) | |
| dc.identifier.citation | Avcı, N. vd. (2012). "Activity and safety of a combination of Epirubicin, Docetaxel and Cisplatin as neoadjuvant treatment for locally advanced breast cancer (LABC): A preliminary report". Annals of Oncology, 23, Supplement 9, 129-129. | |
| dc.identifier.endpage | 129 | |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.issue | Supplement 9 | |
| dc.identifier.startpage | 129 | |
| dc.identifier.uri | https://www.sciencedirect.com/journal/annals-of-oncology/vol/23/suppl/S9 | |
| dc.identifier.uri | http://hdl.handle.net/11452/24493 | |
| dc.identifier.volume | 23 | |
| dc.identifier.wos | 000309409000353 | |
| dc.indexed.wos | SCIE | |
| dc.indexed.wos | CPCIS | |
| dc.language.iso | en | |
| dc.publisher | Elsevier | |
| dc.relation.journal | Annals of Oncology | |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Oncology | |
| dc.subject.wos | Oncology | |
| dc.title | Activity and safety of a combination of Epirubicin, Docetaxel and Cisplatin as neoadjuvant treatment for locally advanced breast cancer (LABC): A preliminary report | |
| dc.type | Other | |
| dc.type.subtype | Meeting Abstract | |
| dc.wos.quartile | Q1 | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi | |
| local.indexed.at | WOS |
Dosyalar
Lisanslı seri
1 - 1 / 1
